IFM Investors Pty Ltd raised its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,257 shares of the semiconductor company’s stock after acquiring an additional 2,034 shares during the period. IFM Investors Pty Ltd’s holdings in Synopsys were worth $15,565,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the stock. Sowell Financial Services LLC grew its position in shares of Synopsys by 2.0% during the fourth quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock valued at $496,000 after purchasing an additional 21 shares in the last quarter. Natural Investments LLC lifted its position in shares of Synopsys by 4.6% in the fourth quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after buying an additional 21 shares in the last quarter. Financial Management Professionals Inc. boosted its stake in Synopsys by 7.0% during the fourth quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock valued at $157,000 after buying an additional 22 shares during the last quarter. Foronjy Financial LLC boosted its stake in Synopsys by 5.2% during the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after buying an additional 22 shares during the last quarter. Finally, Barden Capital Management Inc. grew its holdings in Synopsys by 1.2% during the 4th quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock valued at $877,000 after buying an additional 23 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
SNPS opened at $454.53 on Thursday. The business has a fifty day moving average of $483.60 and a 200 day moving average of $461.62. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market cap of $87.03 billion, a P/E ratio of 105.22, a PEG ratio of 2.62 and a beta of 1.22.
Analysts Set New Price Targets
SNPS has been the topic of several recent research reports. Citigroup upped their price objective on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Bank of America lifted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Morgan Stanley upped their price objective on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Finally, Stifel Nicolaus raised their price objective on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Ten equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $570.06.
Check Out Our Latest Analysis on Synopsys
Insider Activity
In other news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
